People

Dr. Goh Boon Chong received his PhD in Physics from University of Illinois at Urbana-Champaign, USA. He was awarded the SMART Scholars Programme for Postdoctoral Research and joined Peter Dedon’s laboratory in 2016. He leads a multidisciplinary drug discovery program to identify new drugs that negate the resistance mechanism in multidrug-resistant bacteria including Mycobacterium abscessus.

Since year 2019, Dr. Goh has independently developed a phage lysin engineering platform technology that offers a viable therapeutic alternative to treat bacterial infections. Funded by multiple external grants from NRF and NHIC, the lysin engineering platform has generated novel lysins targeting skin and lung infections.

‍